Company intelligence / Profile preview

Tianjin Shiji Kangtai Biomedical Engineering

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

The company is a leading Chinese developer and manufacturer of high-end ophthalmic medical devices including artificial intraocular lenses and collagen-based biomaterials. It has pioneered several first-in-China technologies such as edge-enhanced zero spherical aberration intraocular lenses and hollow-loop foldable intraocular lenses. Its products are used for cataract surgery and ocular wound healing; the company is expanding production capacity with a new facility expected to reach full output by end of 2023.

Therapeutic areas: Ophthalmology
Modalities: DeviceBiologicBiomaterial
Industry: Implantable Medical Devices

Partnerships

Long-term strategic partnerships with multiple colleges/universities for R&D collaboration

Beyond the preview

Go deeper on Tianjin Shiji Kangtai Biomedical Engineering.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianjin Shiji Kangtai Biomedical Engineering.

Explore the full profile